Interactions between acute lymphoblastic leukemia and bone marrow stromal cells influence response to therapy.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis

• Publication date

  2012-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.leukres.2011.08.001PMID 21889797
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia.

  2010cited by this paper
• The leukemic stem cell niche: current concepts and therapeutic opportunities.

  2009cited by this paper
• CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers

  2009cited by this paper
• The role of tumor cell-derived connective tissue growth factor (CTGF/CCN2) in pancreatic tumor growth.

  2009cited by this paper
• Characterization of early stages of human B cell development by gene expression profiling

  2009cited by this paper
• Acute lymphoblastic leukaemia.

  2008influential reference
• A paracrine requirement for hedgehog signalling in cancer

  2008cited by this paper
• Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia.

  2008cited by this paper
• PAX5/TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cells.

  2008cited by this paper
• Bone marrow fibrosis in childhood acute lymphoblastic leukemia correlates to biological factors, treatment response and outcome

  2008cited by this paper
• Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study

  2008cited by this paper
• Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia

  2008cited by this paper
• Stromal gene signatures in large-B-cell lymphomas.

  2008cited by this paper
• CCN family 2/connective tissue growth factor modulates BMP signalling as a signal conductor, which action regulates the proliferation and differentiation of chondrocytes.

  2008cited by this paper
• The role of BSG (CD147) in acute lymphoblastic leukaemia and relapse

  2008cited by this paper
• Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study.

  2008cited by this paper
• The warburg effect in leukemia-stroma cocultures is mediated by mitochondrial uncoupling associated with uncoupling protein 2 activation.

  2008cited by this paper
• High expression of connective tissue growth factor in pre‐B acute lymphoblastic leukaemia

  2007influential reference
• Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia

  2007cited by this paper
• GSEA-P: a desktop application for Gene Set Enrichment Analysis

  2007cited by this paper
• Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase.

  2007cited by this paper
• Characterization of Early Stages of Human B Cell Development by Gene Expression Profiling1

  2007cited by this paper
• Pax5: the guardian of B cell identity and function

  2007cited by this paper
• Connective tissue growth factor (CTGF) expression and outcome in adult patients with acute lymphoblastic leukemia.

  2007cited by this paper
• Authenticity and drug resistance in a panel of acute lymphoblastic leukaemia cell lines

  2006cited by this paper
• Altered glucose metabolism in childhood pre-B acute lymphoblastic leukaemia

  2006influential reference
• Connective tissue growth factor–specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancer

  2006cited by this paper
• The gene expression signature of relapse in paediatric acute lymphoblastic leukaemia: implications for mechanisms of therapy failure

  2005cited by this paper
• IL-7 Receptor Signals Inhibit Expression of Transcription Factors TCF-1, LEF-1, and RORγt

  2004cited by this paper
• Classification of pediatric acute lymphoblastic leukemia by gene expression profiling.

  2003cited by this paper
• A structural approach to the role of CCN (CYR61/CTGF/NOV) proteins in tumourigenesis

  2003cited by this paper
• The CCN family: a new stimulus package.

  2003cited by this paper
• Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling.

  2002cited by this paper
• Stromal cells regulate survival of B-lineage leukemic cells during chemotherapy.

  2000cited by this paper
• Functionally distinct human marrow stromal cell lines immortalized by transduction with the human papilloma virus E6/E7 genes.

  1995cited by this paper

• Hypoxic conditions confer chemoresistance to crizotinib but not to imatinib in chronic myeloid leukemia cells

  2026cites this paper
• Disruption of constitutive CXCR4 oligomers impairs oncogenic properties in lymphoid neoplasms

  2025cites this paper
• A TIM-3-Fc decoy secreted by engineered T cells improves CD19 CAR-T cell therapy in B-cell acute lymphoblastic leukemia.

  2025cites this paper
• The dynamic interaction of pediatric ALL cells and MSCs: influencing leukemic cell survival and modulating MSC β-catenin expression

  2025cites this paper
• The critical role of the bone marrow stromal microenvironment for development of drug screening platforms in leukemia.

  2024cites this paper
• Disruption of basal CXCR4 oligomers impairs oncogenic properties in lymphoid neoplasms

  2024cites this paper
• Inflammation as a driver of hematological malignancies

  2024cites this paper
• High BMP4 expression in low/intermediate risk BCP-ALL identifies children with poor outcomes

  2022cites this paper
• PROM1 and CTGF Expression in Childhood MLL-Rearrangement Acute Lymphoblastic Leukemia

  2022cites this paper
• CCN2 (Cellular Communication Network factor 2) in the bone marrow microenvironment, normal and malignant hematopoiesis

  2021cites this paper
• Leukemia-Induced Cellular Senescence and Stemness Alterations in Mesenchymal Stem Cells Are Reversible upon Withdrawal of B-Cell Acute Lymphoblastic Leukemia Cells

  2021cites this paper
• Bone marrow MSC from pediatric patients with B-ALL highly immunosuppress T-cell responses but do not compromise CD19-CAR T-cell activity

  2020cites this paper
• OTT_A_249425 6583..6591

  2020cites this paper
• Mesenchymal soluble factors confer imatinib drug resistance in chronic myelogenous leukemia cells

  2020cites this paper
• Targeting CXCR4 in AML and ALL

  2020cites this paper
• The CXCR4 Antagonist, AMD3100, Reverses Mesenchymal Stem Cell-Mediated Drug Resistance in Relapsed/Refractory Acute Lymphoblastic Leukemia

  2020cites this paper
• Acute Lymphoblastic Leukaemia Cells Impair Dendritic Cell and Macrophage Differentiation: Role of BMP4

  2019cites this paper
• Prognostic significance of CXCR4 expression in acute myeloid leukemia

  2019cites this paper
• Targeting cyclooxygenase by indomethacin decelerates progression of acute lymphoblastic leukemia in a xenograft model.

  2019cites this paper
• New therapeutic opportunities from dissecting the pre-B leukemia bone marrow microenvironment

  2018cites this paper
• The BMP pathway: A unique tool to decode the origin and progression of leukemia.

  2018cites this paper
• Epidemiology and biology of relapse after stem cell transplantation

  2018cites this paper
• The BMP Pathway: a unique tool to decode origin and progression of Leukemia

  2018cites this paper
• Eviction from the sanctuary: Development of targeted therapy against cell adhesion molecules in acute lymphoblastic leukemia.

  2017cites this paper
• Abundant and equipotent founder cells establish and maintain acute lymphoblastic leukaemia

  2017cites this paper
• Pediatric precursor B acute lymphoblastic leukemia: are T helper cells the missing link in the infectious etiology theory?

  2017cites this paper
• Bone Marrow Microenvironment regulation of BCL6 in Acute Lymphoblastic Leukemia

  2016cites this paper
• High expression of connective tissue growth factor accelerates dissemination of leukaemia

  2016cites this paper
• Bone marrow microenvironment modulation of acute lymphoblastic leukemia phenotype.

  2016cites this paper
• Modeling Chemotherapy Resistant Leukemia In Vitro.

  2016cites this paper
• Characterization of Rare, Dormant, and Therapy-Resistant Cells in Acute Lymphoblastic Leukemia

  2016cites this paper
• Determining the prognostic significance of PI3K/Akt/mTOR and JAK/STAT5 signaling pathways in pediatric acute lymphoblastic leukemia using single-cell analysis

  2015cites this paper
• Modeling The Bone Marrow Microenvironment's Influence on Leukemic Disease.

  2015cites this paper
• The role of CCN family genes in haematological malignancies

  2015cites this paper
• The Bone Marrow-Mediated Protection of Myeloproliferative Neoplastic Cells to Vorinostat and Ruxolitinib Relies on the Activation of JNK and PI3K Signalling Pathways

  2015cites this paper
• MAPK signaling cascades mediate distinct glucocorticoid resistance mechanisms in pediatric leukemia.

  2015cites this paper
• Rapamycin interacts synergistically with idarubicin to induce T-leukemia cell apoptosis in vitro and in a mesenchymal stem cell simulated drug-resistant microenvironment via Akt/mammalian target of rapamycin and extracellular signal-related kinase signaling pathways

  2014cites this paper
• Decreased Expression of CXCR4 Chemokine Receptor in Bone Marrow after Chemotherapy in Patients with Non-Hodgkin Lymphomas Is a Good Prognostic Factor

  2014influential citation
• Targeting connective tissue growth factor (CTGF) in acute lymphoblastic leukemia preclinical models: anti-CTGF monoclonal antibody attenuates leukemia growth

  2014cites this paper
• CRIF1 Interacting with CDK2 Regulates Bone Marrow Microenvironment-Induced G0/G1 Arrest of Leukemia Cells

  2014cites this paper
• Hypomethylation of the CTGF gene locus is a common feature of paediatric pre‐B acute lymphoblastic leukaemia

  2013cites this paper
• Bone marrow mesenchymal stromal cells affect the cell cycle arrest effect of genotoxic agents on acute lymphocytic leukemia cells via p21 down-regulation

  2013influential citation
• Early lymphoid development and microenvironmental cues in B-cell acute lymphoblastic leukemia.

  2012cites this paper